What Is The Buzz Surrounding Therapy Cells Inc (OTCMKTS:TCEL)?

In yesterday’s trading session, the stock price of Therapy Cells Inc (OTCMKTS:TCEL) declined 50% to close the trading session at $0.00040. The decline was supported by massive share volume of 341.78 million compared to average monthly share volume of 31.05 million. Prior to that, the stock closed almost flat, in spite of all the intra-day decline and spikes.

The momentum

The decline recorded in yesterday’s trading session is not at all surprising. After all, to know where a stock may be moving, one needs to do some thorough analysis of the company’s overall performance. Well, Therapy Cells has not filed its financial report for the second quarter of 2015. As a result, its OTC profile highlights a red warning sign which is comparable to a glaring hint.

There is no evident way to know how company is performing in these days. However, if the last report is analyzed, the investors are going to feel disappointed. As per the last filed report for 1Q2015, Therapy Cell reported cash of $246, with no thousands added to it. The total current assets came at $51,000 whereas the total liabilities stood at $918,000. It has generated no revenue since inception and net loss in 1Q2015 was $7,000.

The highlights

Even after reading the numbers, there are many investors who are inclined to stay invested in the stock. Well, they should not disregard the horrible state of share dilution. As of March 31, 2014 Therapy Cells outstanding share stood at 153 million which then surged to 1.7 billion in a matter of just one year. The numbers clearly indicate there is a lot of dilution going on, and therefore utmost caution should be followed before any making any substantial investment.

TCEL

Therapy Cells Inc (OTCMKTS:TCEL) experienced a sharp decline from $0.0011 to $0.0004 in just 2 sessions and the loss of 50% suffered in the last trading session was just a part of it. The volume surged to 341 million against the much poorer daily average of 60 million, reflecting a strong bout of capitulation on the part of frustrated investors. The stock is already trading in the area of the lowest 5 ticks possible and only 3 ticks away from the lowest tick of $0.0001. The congestion zone of $0.0003-$0.0004 can provide a little bit of support but a retest of $0.0001 can’t be ruled out.

Legal Notice: This work is based on what we’ve learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It’s your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Don’t trade in these markets with money you can’t afford to lose. Investing in stock markets involves the risk of loss. Before investing you should consider carefully the risks involved, if you have any doubt as to suitability or the taxation implications, seek independent financial advice. StocksnTrade expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, StocksnTrade, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast.

(c) 2018 StocksnTrade. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of StocksnTrade. See site disclaimer for compensation.

Beth Aguilar

Beth Aguilar

Beth graduated with her bachelor’s degree in political communications from Dallas University. She loves to covering stories behind Wall Street's biggest price moves and the trends affecting market sectors.

Leave a Response